-
Product Insights
NewLuminex Corp Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Luminex Corp Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Luminex Corp (Luminex) develops, manufactures and markets proprietary biological testing technologies. The company offers a wide range of products including assays, instruments, reagents and accessories, software and replacement parts. It employs proprietary technologies to test for proteins and nucleic acids, and to serve multiplexing, precision, sensitivity, accuracy, and for reduction of labor. Luminex offers its products to various markets such...
-
Product Insights
NewBiocartis Group NV Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Biocartis Group NV Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Biocartis Group NV (Biocartis) operates as a molecular diagnostics company. It provides personalized medicine for patients through its molecular diagnostics. The company undertakes the development of diagnostics technology platforms for multiplexed detection of bio-analytes, with oncology as its key focus area. Its Idylla is a molecular diagnostics system that provides easy access to clinical molecular diagnostic information. Biocartis also...
-
Product Insights
NewMedMira Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our MedMira Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. MedMira Inc (MedMira) is a developer, manufacturer and marketer of rapid diagnostics and technology platforms. The company offers products in the areas of HIV, H. pylori, multiplex, syphilis, miriad rvf toolkit, and tissue and eye banks. MedMira offers Miriad RVF toolkit that facilitates the development and commercialization of rapid diagnostics. The company serves hospitals, point-of-care facilities, laboratories, governments, public health...
-
Product Insights
NewArcherDx Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our ArcherDx Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. ArcherDx Inc (ArcherDx) is a molecular technology company that develops customized genomic medicine-based solutions for the discovery of various types of cancer, auto-immune, and other genetic diseases. It offers comprehensive next-generation sequencing (NGS) assays that enable the detection of deoxyribonucleic acid (DNA)-based variant and copy-number variation (CNV); sensitive variant from circulating tumor (ct) DNA; ribonucleic acid (RNA)-based fusion, expression and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Halobetasol Propionate in Plaque Psoriasis (Psoriasis Vulgaris)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Halobetasol Propionate in Plaque Psoriasis (Psoriasis Vulgaris) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Halobetasol Propionate in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BEAM-101 in Beta Thalassaemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BEAM-101 in Beta Thalassaemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BEAM-101 in Beta Thalassaemia Drug Details: BEAM-101 is under development for the...
-
Product Insights
Human Immunodeficiency Virus (HIV) Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
HIV Tests Pipeline Market Report Overview Human Immunodeficiency Virus (HIV) tests refer to the antigens, antibodies, and nucleic acid reagent tests performed for the detection of HIV type I. The HIV Tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...
-
Sector Analysis
COVID-19 Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
COVID-19 tests Market Report Overview The COVID-19 tests market size was valued at $23.97 billion in 2023. The market will decline at a CAGR of more than 22%. COVID-19 tests are used to screen for and identify infections caused by the SARS-CoV-2- coronavirus, an emerging pathogen that was first discovered in China in the early 21st century. The COVID-19 test can be performed using point-of-care rapid testing, laboratory-based ELISA testing, or PCR. COVID-19 Tests Market Outlook 2023-2033 ($ Billion) Buy...
-
Sector Analysis
BRCA Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
BRCA Tests Market Report Overview The BRCA test market size was $4.3 million in 2023. The considerable increase in the incidence of breast and ovarian cancer will drive the BRCA tests market to grow at a CAGR of more than 3% during 2023-2033. Rates of BRCA1/2 testing have increased in recent years. This is due to a lowering in the costs associated with BRCA1/2 screening, increased public awareness, and the availability of PARP inhibitors to treat breast and ovarian cancer...